Lesion of descending 5-HT pathways increases zimeldine-induced waking in rats
- 1 May 1995
- journal article
- Published by Elsevier in Physiology & Behavior
- Vol. 57 (5) , 959-966
- https://doi.org/10.1016/0031-9384(94)00370-k
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Re-examination of the effects of raphe lesions on the sleep/wakefulness cycle states in catsJournal of Sleep Research, 1993
- The 5-HT1A antagonist (−)-alprenolol fails to modify sleep or zimeldine-induced sleep-waking effects in ratsPharmacology Biochemistry and Behavior, 1992
- Depletion of brain serotonin differently affects behaviors induced by 5HT1A, 5HT1C, and 5HT2 receptor activation in ratsBehavioral and Neural Biology, 1991
- Effects of zimeldine, a selective 5-HT reuptake inhibitor, combined with ritanserin, a selective 5-HT2 antagonist, on waking and sleep stages in ratsBehavioural Brain Research, 1990
- The relative contribution of ascending and descending serotonergic pathways in p-Chloroamphetamine-induced antinociceptionPharmacology Biochemistry and Behavior, 1988
- 3: Regulation of Pain Sensitivity, Influence of ProstaglandinsCephalalgia, 1986
- Selective Neurotoxic Lesions of Descending Serotonergic and Noradrenergic Pathways in the RatJournal of Neurochemistry, 1985
- Endogenous Pain Control Systems: Brainstem Spinal Pathways and Endorphin CircuitryAnnual Review of Neuroscience, 1984
- Time course of changes in nociception after 5,6-dihydroxytryptamine lesions of descending 5-HT pathwaysPharmacology Biochemistry and Behavior, 1983
- EFFECTS OF 5,6‐DIHYDROXYTRYPTAMINE ON MONOAMINERGIC NEURONES IN THE CENTRAL NERVOUS SYSTEM OF THE RATJournal of Neurochemistry, 1972